COVID-19 Trial Tracker Updates

In April 2020, Cytel launched an open-access global COVID-19 Clinical Trial Tracker to help facilitate greater collaboration between researchers, policymakers, clinicians, journalists, philanthropists, and other critical stakeholders. Funded in part by The Bill and Melinda Gates Foundation, a leader in global health solutions, this live dashboard offers an overview of all the clinical trials taking place in the international effort to tackle the pandemic.

There are currently 2533 registered interventional trials worldwide which include 343 for hydroxychloroquine, 111 for lopinavir/ritonavir, 94 using stem cell therapies, 93 for Azithromycin therapies, 165 for plasma based therapies and 70 for tocilizumab. Read more here.

(Source: Cytel Blog; 1/19/20)